The world doesn't need all these manufacturers of contact lenses. Producing a supply that drastically outnumbers the demand isn't feasible i.e. lumify. Companies like b+l brought it upon themselves and might be bought by a private equity firm. The private equity firm is going to want to move product and fire deadweight. They will try to cut costs and undercut companies like alcon and they will be able to. That's my best guess. Is that good for capitalism? I say no. Let the deadweight companies like b+l find a way to make their business work or die trying.
It's the approach to managing headcount at GSK within an increasingly diminished footprint of relevance.